Inventiva SA ADR IVA 深 沪
等待开盘 01-30 09:30:00 美东时间
6.32
-0.510
-7.47%
华盛通- 最 高6.55
- 今 开6.38
- 成交量 47.52万股
- 最 低 6.25
- 昨 收 6.83
- 总市值 8.78亿
- 52周最高 7.9825
- 市盈率 静 --
- 换手率 0.34%
- 52周最低 2.2312
- 委 比 77.41%
- 总股本 1.39亿
- 历史最高 19.064
- 量 比 0.81
- 振 幅 4.39%
- 历史最低 1.53
- 每 手 1
- 风险率 1.13%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 希捷科技、德州仪器、HCA控股、通用汽车、波音、UPS等或多家机构上调目标价；布朗保险、康沃系统、Qorvo、联合健康等遭多家机构下调目标价
今日重点评级关注：Piper Sandler：维持Praxis Precision Medicine"超配"评级，目标价从450美元升至1200美元；Tigress Financial：维持Main International ETF"买入"评级，目标价从52美元升至66美元
01-29 11:06
Biotech Inventiva's 50% surge shows investor optimism over liver disease drug
Biotech Inventiva's 50% surge shows investor optimism over liver disease drug Inventiva shares up 50% in January Optimism builds around its MASH drug Big Pharma signal strategic interest A lot riding out Phase 3 outcome Evaluating funding options, CEO tells Reuters By Danilo Masoni MILAN, Jan 28 (Re
01-28 23:36
Barclays Initiates Coverage On Inventiva with Overweight Rating, Announces Price Target of $18
Barclays analyst Eliana Merle initiates coverage on Inventiva (NASDAQ:IVA) with a Overweight rating and announces Price Target of $18.
01-28 22:40
美股周涨跌榜 | 算力基建再提速！Galaxy Digital 涨超37%，获批电力容量翻番；创新药企IBRX大涨近137%
算力基建再提速！Galaxy Digital 周涨超37%，获批电力容量翻番；创新药企IBRX周涨近137%，在研创新药获批上市>>
01-17 10:31
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Leerink Partners Initiates Coverage On Inventiva with Outperform Rating, Announces Price Target of $12
Leerink Partners analyst Thomas Smith initiates coverage on Inventiva (NASDAQ:IVA) with a Outperform rating and announces Price Target of $12.
01-12 20:37
Why LexinFintech Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Shares of LexinFintech Holdings Ltd – ADR (NASDAQ:LX) rose sharply in pre-marke...
2025-11-24 18:23
Inventiva S.A reports 9M results
Inventiva S.A (IVA): Revenues for the first nine months of 2025 amounted to €4.5 million, compared to none generated for the same period in 2024. Cash and cash equivalents at €97.6 million, and €24.7 ...
2025-11-22 05:05
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
2025-11-19 11:01
Guggenheim Maintains Buy on Inventiva, Lowers Price Target to $11
Guggenheim analyst Seamus Fernandez maintains Inventiva (NASDAQ:IVA) with a Buy and lowers the price target from $13 to $11.
2025-11-18 22:16
